Reference 18
Faecal occult blood testing (FOBT) for population health screening
Faecal occult blood testing (FOBT) for population health screening
Reference No. | 18 |
| Reference Name | Faecal occult blood testing (FOBT) for population health screening |
| Advisory Panel | Professor Brendon Kearney (Chair and MSAC member) Professor Sydney Bell (MSAC member) Dr David Deam (Royal College of Pathologists of Australasia nominee) Professor Les Irwig (co-opted member) Associate Professor Michael Solomon (Colorectal Surgical Society of Australasia nominee) Professor Graeme Young (Gastroenterological Society of Australia nominee) Elizabeth Symons (Consumers' Health Forum of Australia nominee) |
| Date Received by MSAC Secretariat | August 2002 |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | This assessment was considered by the MSAC at the 19 May 2004 meeting. The MSAC considers that faecal occult blood testing is useful for population health screening to reduce colorectal cancer (CRC). There was no available evidence suitable for the assessment of the comparative performance of currently available immunochemical tests within an average-risk population health screening setting. It is suggested that currently available and new immunochemical tests with promising technical characteristics be evaluated against established FOBTs within the context of an ongoing screening program. |
| Stage 4 - Decision |  |
| Stage 5 - Implementation | |
Page currency, Latest update: 30 March, 2009
